Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 9 | 2024 | 610 | 0.780 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2022 | 484 | 0.690 |
Why?
|
| Pancreatic Diseases | 1 | 2013 | 13 | 0.410 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2018 | 107 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 847 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2022 | 254 | 0.270 |
Why?
|
| Abdominal Fat | 2 | 2017 | 17 | 0.250 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 58 | 0.220 |
Why?
|
| Retrospective Studies | 9 | 2024 | 2662 | 0.210 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 80 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 434 | 0.190 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2022 | 3 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 485 | 0.180 |
Why?
|
| Humans | 19 | 2024 | 29211 | 0.170 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 58 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 55 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 59 | 0.150 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 47 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 84 | 0.140 |
Why?
|
| Subcutaneous Fat | 2 | 2017 | 17 | 0.140 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 21 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2019 | 108 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 197 | 0.130 |
Why?
|
| Urogenital Abnormalities | 1 | 2017 | 4 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 305 | 0.130 |
Why?
|
| Uterus | 1 | 2017 | 31 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 8 | 0.130 |
Why?
|
| Lung | 1 | 2020 | 389 | 0.130 |
Why?
|
| Tamoxifen | 1 | 2017 | 34 | 0.130 |
Why?
|
| Female | 12 | 2024 | 15825 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2017 | 65 | 0.130 |
Why?
|
| Hysterectomy | 1 | 2017 | 86 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 172 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 198 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 556 | 0.110 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 5 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 685 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 36 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 72 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 419 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 153 | 0.100 |
Why?
|
| Obesity | 2 | 2019 | 705 | 0.090 |
Why?
|
| ROC Curve | 2 | 2022 | 144 | 0.070 |
Why?
|
| Necrosis | 2 | 2022 | 85 | 0.070 |
Why?
|
| Aged | 4 | 2019 | 5648 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2022 | 2442 | 0.060 |
Why?
|
| Child | 1 | 2013 | 2354 | 0.060 |
Why?
|
| Bevacizumab | 2 | 2019 | 106 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 226 | 0.060 |
Why?
|
| Adiposity | 2 | 2019 | 96 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 236 | 0.060 |
Why?
|
| Middle Aged | 4 | 2019 | 7495 | 0.060 |
Why?
|
| Prognosis | 2 | 2019 | 817 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 2070 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 484 | 0.050 |
Why?
|
| Supervised Machine Learning | 1 | 2022 | 8 | 0.050 |
Why?
|
| Drainage | 1 | 2022 | 45 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2022 | 21 | 0.040 |
Why?
|
| Endoscopy | 1 | 2022 | 57 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 70 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 121 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 32 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 17 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 126 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 102 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 40 | 0.040 |
Why?
|
| Philadelphia Chromosome | 1 | 2019 | 1 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 48 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2019 | 46 | 0.040 |
Why?
|
| Algorithms | 1 | 2022 | 434 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 210 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 24 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 483 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 95 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 129 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 166 | 0.030 |
Why?
|
| Amenorrhea | 1 | 2017 | 5 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 794 | 0.030 |
Why?
|
| Pelvic Pain | 1 | 2017 | 10 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 29 | 0.030 |
Why?
|
| Vagina | 1 | 2017 | 45 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 271 | 0.030 |
Why?
|
| Abdomen | 1 | 2017 | 41 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 97 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2016 | 15 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 314 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 104 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 70 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 276 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1288 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 288 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 226 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 233 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 415 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 430 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 881 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 417 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 828 | 0.030 |
Why?
|
| Carboplatin | 1 | 2014 | 121 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 784 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 303 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 115 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 179 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2014 | 201 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 467 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 416 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1684 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 3255 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 4870 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 8130 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 10806 | 0.010 |
Why?
|